An effective vaccine is needed to halt the spread of the severe acute respiratory syndrome
coronavirus-2 (SARS-CoV-2) pandemic. Recently, we reported safety, tolerability and …

T cells directed against mutant neo-epitopes drive cancer immunity. However, spontaneous
immune recognition of mutations is inefficient. We recently introduced the concept of …

BNT162b2, a nucleoside-modified mRNA formulated in lipid nanoparticles that encodes the
SARS-CoV-2 spike glycoprotein (S) stabilized in its prefusion conformation, has …

Background: People with lung cancer usually present at a late stage in the course of their
disease when their chances of long-term survival are low. At present there is little to offer for …

BNT162b2, a lipid nanoparticle (LNP) formulated nucleoside-modified messenger RNA (mRNA)
encoding the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike …

An effective vaccine is needed to halt the spread of the SARS-CoV-2 pandemic. Recently,
we reported safety, tolerability and antibody response data from an ongoing placebo-…

The cancer-associated antigen NY-ESO-1 is expressed in a number of malignancies of
different histological type. Patients with NY-ESO-1 expressing tumors have been shown to bear …

Background BNT162b2, an mRNA vaccine against COVID-19, is being utilised worldwide,
but immunogenicity and safety data in Chinese individuals are limited. Methods This phase 2, …

… 3 , Ulrich Luxemburger …

To identify genes that are involved in ischemia response of the brain, we have evaluated
changes of gene expression in rat cerebrum after 15 min complete global ischemia, followed by …